Emerging role of clinical mass spectrometry in pathology

44Citations
Citations of this article
127Readers
Mendeley users who have this article in their library.

Abstract

Mass spectrometry-based assays have been increasingly implemented in various disciplines in clinical diagnostic laboratories for their combined advantages in multiplexing capacity and high analytical specificity and sensitivity. It is now routinely used in areas including reference methods development, therapeutic drug monitoring, toxicology, endocrinology, paediatrics, immunology and microbiology to identify and quantify biomolecules in a variety of biological specimens. As new ionisation methods, instrumentation and techniques are continuously being improved and developed, novel mass spectrometry-based clinical applications will emerge for areas such as proteomics, metabolomics, haematology and anatomical pathology. This review will summarise the general principles of mass spectrometry and specifically highlight current and future clinical applications in anatomical pathology.

Cite

CITATION STYLE

APA

Fung, A. W. S., Sugumar, V., Ren, A. H., & Kulasingam, V. (2020, February 1). Emerging role of clinical mass spectrometry in pathology. Journal of Clinical Pathology. BMJ Publishing Group. https://doi.org/10.1136/jclinpath-2019-206269

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free